AU6008000A - Chemical compounds-ii - Google Patents

Chemical compounds-ii

Info

Publication number: AU6008000A
Authority: AU; Australia
Prior art keywords: chemical compounds; compounds; chemical
Prior art date: 1999-07-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU60080/00A

Inventor

Allan Fletcher

Howard Langham Mansell

Nathaniel Julius Monck

Alan John Nelson

Mike Snape

Kelly Jean Stanhope

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ligand UK Research Ltd

Original Assignee

Vernalis Research Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-07-23

Filing date

2000-07-21

Publication date

2001-02-13

2000-07-21 Application filed by Vernalis Research Ltd filed Critical Vernalis Research Ltd

2001-02-13 Publication of AU6008000A publication Critical patent/AU6008000A/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Toxicology (AREA)
Ophthalmology & Optometry (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU60080/00A 1999-07-23 2000-07-21 Chemical compounds-ii Abandoned AU6008000A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB9917386		1999-07-23
GBGB9917386.6A GB9917386D0 (en)	1999-07-23	1999-07-23	Chemical compounds-II
PCT/GB2000/002841 WO2001007023A2 (en)	1999-07-23	2000-07-21	Azetidine compounds in cns and eye diseases

Publications (1)

Publication Number	Publication Date
AU6008000A true AU6008000A (en)	2001-02-13

Family

ID=10857864

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU60080/00A Abandoned AU6008000A (en)	1999-07-23	2000-07-21	Chemical compounds-ii

Country Status (5)

Country	Link
EP (1)	EP1212054A2 (en)
JP (1)	JP2003505414A (en)
AU (1)	AU6008000A (en)
GB (1)	GB9917386D0 (en)
WO (1)	WO2001007023A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2004233644A1 (en) *	2003-05-01	2004-11-11	Vernalis Research Limited	The use of azetidinecarboxamide derivatives in therapy
DE602004024880D1 (en) *	2003-05-01	2010-02-11	Vernalis Res Ltd	AZETIDINCARBOXAMIDE DERIVATIVES FOR THE USE OF THE TREATMENT OF CB1-RECEPTOR-MEDIATED DISEASES
JP2006525299A (en) *	2003-05-01	2006-11-09	ヴァーナリスリサーチリミテッド	Azetidine carboxamide derivatives and their use in the treatment of CB1 receptor mediated disorders
US11141404B1 (en)	2020-11-18	2021-10-12	Anebulo Pharmaceuticals, Inc.	Formulations and methods for treating acute cannabinoid overdose
WO2023064225A1 (en)	2021-10-11	2023-04-20	Anebulo Pharmaceuticals, Inc.	Crystalline forms of a cannabinoid receptor type 1 (cb1) modulator and methods of use and preparation thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4226861A (en) *	1978-04-18	1980-10-07	A. H. Robins Company, Inc.	N-Lower-alkyl 3-phenoxy-1-azetidinecarboxamides
IL68699A (en) *	1982-08-19	1986-08-31	Robins Co Inc A H	3-phenoxy-1-azetidine-carboxamides,their preparation and pharmaceutical compositions containing them
US4505907A (en) *	1982-09-02	1985-03-19	A. H. Robins Company, Inc.	N-Formyl and N-hydroxymethyl-3-phenoxy-1-azetidinecarboxamides
IE58943B1 (en) *	1985-02-28	1993-12-01	Robins Co Inc A H	3-Aryloxy-azetidine-carboxamides
US5095014A (en) *	1990-12-07	1992-03-10	A. H. Robins Company, Incorporated	3-(2-chloro-4-(trifluoromethyl)phenoxy)-1-azetidine carboxamides having anticonvulsant activity
US5183903A (en) *	1991-11-26	1993-02-02	A. H. Robins Company, Incorporated	Urea fusion process for the synthesis of 3-phenoxy-1-azetidinecarboxamides
AU2287499A (en) *	1998-01-23	1999-08-09	Cerebrus Pharmaceuticals Limited	Azetidinecarboxamide derivatives for treating cns disorders
GB9801501D0 (en) *	1998-01-23	1998-03-18	Cerebrus Ltd	Chemical compounds - II
GB9917385D0 (en) *	1999-07-23	1999-09-22	Cerebrus Ltd	Chemical compounds-I

1999
- 1999-07-23 GB GBGB9917386.6A patent/GB9917386D0/en not_active Ceased
2000
- 2000-07-21 AU AU60080/00A patent/AU6008000A/en not_active Abandoned
- 2000-07-21 JP JP2001511909A patent/JP2003505414A/en not_active Withdrawn
- 2000-07-21 WO PCT/GB2000/002841 patent/WO2001007023A2/en not_active Ceased
- 2000-07-21 EP EP00946208A patent/EP1212054A2/en not_active Withdrawn

Also Published As

Publication number	Publication date
WO2001007023A3 (en)	2001-05-25
GB9917386D0 (en)	1999-09-22
WO2001007023A2 (en)	2001-02-01
EP1212054A2 (en)	2002-06-12
JP2003505414A (en)	2003-02-12

Publication	Publication Date	Title
AU1173201A (en)	2001-05-14	Skin-gripper
AU3092999A (en)	2000-10-04	Digital-timeshare-exchange
AU5967600A (en)	2001-02-13	Candystraw
AU4115400A (en)	2000-11-14	Short-circuiter
AU6335000A (en)	2001-04-24	Depthimeter
AU2023701A (en)	2001-06-18	Sketcher
AU6440900A (en)	2001-03-13	Homogentisate-dioxygenase
AU2804600A (en)	2000-09-04	Arylaminoalkylamides
AU4916900A (en)	2000-12-05	Benzofuranylsulfonates
AU6008000A (en)	2001-02-13	Chemical compounds-ii
AUPQ319799A0 (en)	1999-10-28	Chemical methods
AU7617200A (en)	2001-04-30	Chemical feeder
AU1901801A (en)	2001-05-30	Glucofuranoses
AU7513400A (en)	2001-04-30	Hydantoin-racemase
AU1915601A (en)	2001-06-06	Periotome
AU2582200A (en)	2000-09-14	Windturbine
AU4435300A (en)	2000-11-10	Hula-hoop
AU6006000A (en)	2001-02-13	Chemical compounds-iii
AU2197301A (en)	2001-06-25	Microlamp
AU5416100A (en)	2001-01-31	Retinoscopes
AU1737601A (en)	2001-05-08	Collectalbum
AU7567500A (en)	2001-05-08	Duckboard
AU5487300A (en)	2001-01-02	Benzylpiperazinyl-indolinylethanones
AU5689400A (en)	2001-01-09	Chemical compounds
AUPQ315399A0 (en)	1999-10-21	Chemical methods

Legal Events

Date	Code	Title	Description
2001-06-21	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
2001-12-20	TH	Corrigenda	Free format text: IN VOL 15, NO 20, PAGE(S) 4277-4282 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 60080/00
2002-05-02	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase